Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8

Diabetes Technology& Therapeutics Aug 2017, Vol. 19, No. 8: 463-470.

Source: Diabetes Technology - August 1, 2017 Category: Endocrinology Authors: Cynthia Harris Thomas Forst Tim Heise Leona Plum-M örschel Elaine Watkins Qianyi Zhang Ludi Fan Parag Garhyan Niels Porksen Source Type: research